|
|
Soluble programmed death-ligand 1 as a prognostic biomarker for overall survival in patients with diffuse large B-cell lymphoma: a replication study and combined analysis of 508 patients
D. Rossille
,
I. Azzaoui
,
A. L. Feldman
,
M. J. Maurer
,
G. Labouré
et al.
Journal articles
hal-01517052v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
Improvement of overall survival after allogeneic hematopoietic stem cell transplantation for children and adolescents: a three-decade experience of a single institution
E. Brissot
,
F. Rialland
,
X. Cahu
,
M. Strullu
,
N. Corradini
et al.
Journal articles
hal-01278605v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
Recurrent mutations of the exportin 1 gene (XPO1) and their impact on selective inhibitor of nuclear export compounds sensitivity in primary mediastinal B-cell lymphoma
Fabrice Jardin
,
A. Pujals
,
L. Pelletier
,
E. Bohers
,
V. Camus
et al.
Journal articles
hal-01372756v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
High level of soluble programmed cell death ligand 1 in blood impacts overall survival in aggressive diffuse large B-Cell lymphoma: results from a french multicenter clinical trial.
D. Rossille
,
M. Gressier
,
D. Damotte
,
Delphine Maucort-Boulch
,
C. Pangault
et al.
Journal articles
hal-00981338v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|